PCM
CVS icon

Polaris Capital Management’s CVS Health CVS Stock Holding History

Polaris Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.8M Sell
365,200
-152,500
-29% -$13.6M 3.56% 7
2026
Q1 		$37.2M Sell
517,700
-7,600
-1% -$585K 3.04% 9
2025
Q4 		$41.7M Sell
525,300
-77,300
-13% -$6.09M 3.46% 7
2025
Q3 		$45.4M Buy
602,600
+115,500
+24% +$7.92M 2.99% 8
2025
Q2 		$33.6M Sell
487,100
-20,300
-4% -$1.33M 2.24% 15
2025
Q1 		$34.4M Buy
507,400
+17,900
+4% +$1.07M 1.97% 17
2024
Q4 		$22M Buy
489,500
+34,700
+8% +$1.95M 1.06% 40
2024
Q3 		$28.6M Buy
454,800
+3,700
+0.8% +$216K 1.41% 37
2024
Q2 		$26.6M Sell
451,100
-7,200
-2% -$450K 1.43% 36
2024
Q1 		$36.6M Sell
458,300
-43,900
-9% -$3.35M 1.82% 22
2023
Q4 		$39.7M Buy
502,200
+39,100
+8% +$2.78M 1.92% 24
2023
Q3 		$32.3M Sell
463,100
-170,700
-27% -$12.1M 1.74% 29
2023
Q2 		$43.8M Sell
633,800
-26,100
-4% -$1.86M 1.65% 30
2023
Q1 		$49M Sell
659,900
-3,000
-0.5% -$252K 1.83% 28
2022
Q4 		$61.8M Buy
662,900
+10,900
+2% +$1.05M 2.15% 12
2022
Q3 		$62.2M Sell
652,000
-8,100
-1% -$802K 2.44% 8
2022
Q2 		$61.2M Sell
660,100
-20,600
-3% -$2.01M 2.18% 9
2022
Q1 		$68.9M Sell
680,700
-25,600
-4% -$2.69M 2.19% 8
2021
Q4 		$72.9M Sell
706,300
-9,900
-1% -$915K 2.35% 8
2021
Q3 		$60.8M Sell
716,200
-28,700
-4% -$2.4M 1.94% 16
2021
Q2 		$62.2M Sell
744,900
-2,100
-0.3% -$172K 2.01% 16
2021
Q1 		$64.1M Buy
747,000
+84,400
+13% +$6.15M 2.1% 16
2020
Q4 		$45.3M Buy
+662,600
New +$43.1M 1.7% 28

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Polaris Capital Management's CVS Position: Q2 2026 in Review

Polaris Capital Management reduced its CVS Health (CVS) stake by 29% in Q2 2026, selling an estimated $13.6M and leaving 365,200 shares worth $37.8M. The position accounts for 3.56% of the portfolio, ranked #7.

Polaris Capital Management first reported a position in CVS in Q4 2020 and has held it in 23 quarters since. The position peaked at $72.9M in Q4 2021. 2,069 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Polaris Capital Management held 365,200 shares of CVS Health worth $37.8M as of Q2 2026.
  • Polaris Capital Management sold 152,500 CVS Health shares in Q2 2026, an estimated $13.6M.
  • CVS Health made up 3.56% of Polaris Capital Management's portfolio in Q2 2026, its #7 holding.
  • Polaris Capital Management first reported a position in CVS Health in Q4 2020 and has held it in 23 quarters since.
  • Polaris Capital Management's CVS Health position peaked at $72.9M in Q4 2021.
  • 2,069 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Polaris Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.